Profil Institut für Stoffwechselforschung GmbH
48
2
2
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
8 terminated/withdrawn out of 48 trials
82.2%
-4.4% vs industry average
8%
4 trials in Phase 3/4
8%
3 of 37 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (48)
Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
Role: collaborator
CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes
Role: collaborator
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Role: collaborator
Comparison Study of Insulin GZR4 With Insulin Degludec
Role: collaborator
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Role: collaborator
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
Role: collaborator
Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
Role: collaborator
Clinical Experimental Study to Investigate Specific Features of ClampArt®
Role: lead
Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects
Role: collaborator
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
Role: collaborator
Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Role: lead
Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus
Role: lead
Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R
Role: collaborator
Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
Role: lead
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Role: collaborator
Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus
Role: collaborator
Empagliflozin and Sympathetic Nerve Traffic
Role: lead
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Role: collaborator
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
Role: collaborator
Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30
Role: collaborator